The Life Sciences Web Portal for German-speaking Europe
This is a free web portal for the life sciences in German-speaking Europe... » read more
- Deutsche Biotech Innovativ Raises €1.6m in Capital Increase (2015-11-25)
The Deutsche Biotech Innovativ AG ("DBI") was able to generate gross proceeds of over 1.6 million Euros from its current capital increase. In total 48,938 new shares were placed at an issue price of 33.50 Euros. The new shares are expected to be delivered beginning...
- Novartis: EU Approves Heart Failure Medicine Entresto (2015-11-24)
> Decision brings hope of longer and better life with fewer hospitalizations for millions of Europeans with symptomatic chronic heart failure with reduced ejection fraction > Entresto is the first and only treatment to show a significant mortality benefit in a ...
- ObsEva Closes CHF60m Series B Financing (2015-11-23)
ObsEva, a Swiss biopharmaceutical company developing a novel generation of drugs addressing serious conditions compromising pregnancy from conception to birth, today announced the closing of a CHF 60 (USD 60) million Series B preferred equity financing. The financi...
- ObsEva Licenses Non-Asian Rights to KLH-2109 from Kissei (2015-11-23)
ObsEva and Kissei Pharmaceutical Co., Ltd. (“Kissei”) today announced that they have entered into a collaboration agreement to develop and commercialize KLH-2109 for the treatment of endometriosis and other potential indications. KLH-2109 is a novel, oral gonadotro...
- Wilex Unveils Financing Strategy to Develop ADC Technology (2015-11-23)
Ad-hoc release pursuant to § 15 Wertpapierhandelsgesetz (German Securities Trading Act) > Financing strategy approved that will provide liquidity to the Company until the end of 2016 > Rights issue of around 10% using authorised capital with exclusion of sh...
- Merck KGaA Plans to Considerably Expand Presence in Africa (2015-11-20)
> Aim is to more than double sales in Africa to about € 500 million by 2020 Merck, a leading science and technology company, announced today that it plans to considerably expand its presence on the African continent over the next five years and is counting on ...
- Newron Completes CHF5.4m Private Placement (2015-11-20)
Financing Supports Clinical Development of Sarizotan for Patients with Rett Syndrome, a Rare Neurodevelopmental Disease Newron Pharmaceuticals S.p.A. (“Newron”), a research and development company focused on novel CNS and pain therapies, announces that it has ...
- MeVis Medical Announces Results for Third Quarter of 2015 (2015-11-19)
> Sales in the third quarter increased by 33 % to € 4.8 m primarily due to the strong US dollar (prev. year: € 3.6 m) > Earnings before interest and taxes (EBIT) increased to € 3.6 m after nine month (prev. year € 3.2 m), EBIT margin of 30 % > Net profit decl...
- Merck, Univ of Cape Town Partner in Malaria Drug Discovery (2015-11-19)
> Private sector and academic center in Africa join forces in the fight against infectious diseases > Research collaboration leverages competencies and expertise in alignment with Merck’s commitment to improve access to medicines for underserved populations ...
- Probiodrug Reports Third Quarter 2015 Business Update (2015-11-19)
Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer’s disease (AD), today announces its third quarter business update for the period ending 30 September 2015, in the form of an interim manag...
Life-Sciences-Germany.com is your doorway to the life sciences in German-speaking Europe!
[LSG] provides free, up-to-date and structured access to
in Germany, Austria and Switzerland.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSG] is 100% Made in Germany!Start here with the latest News!
To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to firstname.lastname@example.org and simply fill the subject line with the word »LSG newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)